» Articles » PMID: 6141559

Keratolinin: the Soluble Substrate of Epidermal Transglutaminase from Human and Bovine Tissue

Overview
Specialty Science
Date 1984 Jan 1
PMID 6141559
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Substrates of human and bovine epidermal transglutaminase (glutaminyl-peptide gamma-glutamyltransferase, R-glutaminyl-peptide:amine-gamma-glutamyltransferase, EC 2.3.2.13) were isolated and purified by ion exchange chromatography and preparative zone electrophoresis. These substrates of Mr 36,000, which we propose to call keratolinin, incorporated dansylcadaverine and were precipitated by antibody. Keratolinin is ultimately polymerized on the inner leaflet of the keratinocyte membrane to form the cornified envelope. Each Mr 36,000 substrate was dissociated by chaotropic agents or detergents into noncovalent subunits; the Mr of these subunits was 6,000-6,200 on electrophoresis in 15% acrylamide/1% NaDodSO4/6 M urea gels. Isoelectric focusing of human or bovine keratolinin revealed two moieties separated by 0.3-0.4 pH unit (human, 5.4/5.0; bovine, 6.3/6.0). The two proteins were readily resolved by chromatofocusing and each isoelectric moiety of bovine keratolinin incorporated dansylcadaverine by epidermal transglutaminase and calcium and reacted with identity to antiserum to soluble Mr 36,000 keratolinin. Antiserum to human keratolinin failed to crossreact with its bovine counterpart. Antiserum to involucrin did not crossreact with either keratolinin or epidermis by immunodiffusion. Human and bovine epidermal keratolinins are biochemically similar but immunochemically distinct proteins from the epidermis. Involucrin appears only in significant quantities in cell culture.

Citing Articles

MiR-449a suppresses cell invasion by inhibiting MAP2K1 in non-small cell lung cancer.

You J, Zhang Y, Li Y, Fang N, Liu B, Zu L Am J Cancer Res. 2015; 5(9):2730-44.

PMID: 26609480 PMC: 4633902.


Cell cycle- and cancer-associated gene networks activated by Dsg2: evidence of cystatin A deregulation and a potential role in cell-cell adhesion.

Gupta A, Nitoiu D, Brennan-Crispi D, Addya S, Riobo N, Kelsell D PLoS One. 2015; 10(3):e0120091.

PMID: 25785582 PMC: 4364902. DOI: 10.1371/journal.pone.0120091.


A molecular signature of epithelial host defense: comparative gene expression analysis of cultured bronchial epithelial cells and keratinocytes.

Vos J, Datson N, van Kampen A, Luyf A, Verhoosel R, Zeeuwen P BMC Genomics. 2006; 7:9.

PMID: 16420688 PMC: 1382211. DOI: 10.1186/1471-2164-7-9.


Epidermal differentiation characteristics of the psoriatic plaque during treatment with calcipotriol.

van der Vleuten C, de Jong E, van de Kerkhof P Arch Dermatol Res. 1996; 288(7):366-72.

PMID: 8818184 DOI: 10.1007/BF02507105.


Overexpression of human loricrin in transgenic mice produces a normal phenotype.

Yoneda K, Steinert P Proc Natl Acad Sci U S A. 1993; 90(22):10754-8.

PMID: 8248167 PMC: 47856. DOI: 10.1073/pnas.90.22.10754.


References
1.
Buxman M, Wuepper K . Cellular localization of epidermal transglutaminase: a histochemical and immunochemical study. J Histochem Cytochem. 1978; 26(5):340-8. DOI: 10.1177/26.5.77870. View

2.
Rice R, Green H . Relation of protein synthesis and transglutaminase activity to formation of the cross-linked envelope during terminal differentiation of the cultured human epidermal keratinocyte. J Cell Biol. 1978; 76(3):705-11. PMC: 2110014. DOI: 10.1083/jcb.76.3.705. View

3.
Rice R, Green H . Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions. Cell. 1979; 18(3):681-94. DOI: 10.1016/0092-8674(79)90123-5. View

4.
Buxman M, Lobitz C, Wuepper K . Epidermal transglutaminase. Identification and purification of a soluble substrate with studies of in vitro cross-linking. J Biol Chem. 1980; 255(3):1200-3. View

5.
Peterson L, Buxman M . Rat hair follicle and epidermal transglutaminases. Biochemical and immunochemical isoenzymes. Biochim Biophys Acta. 1981; 657(1):268-76. DOI: 10.1016/0005-2744(81)90150-9. View